Recent VTRS News
- Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024 • PR Newswire (US) • 06/07/2024 10:59:00 AM
- Viatris to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference • PR Newswire (US) • 06/04/2024 10:59:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2024 11:16:03 AM
- Viatris Appoints Rogerio Vivaldi Coelho, M.D., to Board of Directors • PR Newswire (US) • 06/03/2024 10:59:00 AM
- Viatris to Participate in the Jeffries Global Healthcare Conference • PR Newswire (US) • 05/31/2024 10:59:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/28/2024 10:00:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/28/2024 08:04:09 PM
- Viatris Publishes 2023 Sustainability Report: Building Sustainable Access at Scale • PR Newswire (US) • 05/21/2024 10:59:00 AM
- U.S. Index Futures Dip, Bank of England Holds Interest Rates at 5.25% • IH Market News • 05/09/2024 11:47:20 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 11:44:13 AM
- Viatris Reports Strong First Quarter 2024 Financial Results and Reaffirms 2024 Financial Guidance Ranges • PR Newswire (US) • 05/09/2024 10:59:00 AM
- Viatris to Participate in the BofA Securities 2024 Health Care Conference • PR Newswire (US) • 05/02/2024 09:00:00 PM
- Viatris Expands its Wellbeing Program with the Launch of Unmind, a Leading Workplace Resource Focused on Mental Health • PR Newswire (US) • 05/01/2024 10:59:00 AM
- Viatris to Report First Quarter 2024 Financial Results on May 9, 2024 • PR Newswire (US) • 04/16/2024 08:30:00 PM
- Viatris Appoints Corinne Le Goff as Chief Commercial Officer • PR Newswire (US) • 04/15/2024 12:00:00 PM
- Viatris Announces Launch of First Bioequivalent Generic Version of Copaxone® 20 mg/mL Once-Daily in Canada • PR Newswire (Canada) • 04/15/2024 10:59:00 AM
- Viatris annonce le lancement de la première version générique bioéquivalente du Copaxone [MD] 20 mg/mL au Canada • PR Newswire (Canada) • 04/15/2024 10:59:00 AM
- Viatris Announces the Launch of RYZUMVl™ (Phentolamine Ophthalmic Solution) 0.75% in the United States • PR Newswire (US) • 04/01/2024 10:59:00 AM
- Viatris Hosts R&D Event Focusing on its Collaboration with Idorsia, Phase 3 Assets Selatogrel and Cenerimod and Key Elements of its Pipeline • PR Newswire (US) • 03/27/2024 10:59:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:29:10 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:24:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 01:09:57 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:54:14 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:47:44 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 12:26:09 AM
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM